BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 6796317)

  • 1. Characterization of an amyloid fibril protein from localized amyloidosis of the skin as lambda immunoglobulin light chains of variable subgroup I (A lambda I).
    Husby G; Sletten K; Blumenkrantz N; Danielsen L
    Clin Exp Immunol; 1981 Jul; 45(1):90-6. PubMed ID: 6796317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid fibril protein related to immunoglobulin lambda-chains.
    Skinner M; Benson MD; Cohen AS
    J Immunol; 1975 Apr; 114(4):1433-5. PubMed ID: 804011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lambda II immunoglobulin light chain protein in primary localized rectal amyloidosis.
    Zaky ZS; Liepnieks JJ; Rex DK; Cummings OW; Benson MD
    Amyloid; 2007 Dec; 14(4):299-304. PubMed ID: 17968691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexistence of protein AA and immunoglobulin light-chain fragments in amyloid fibrils.
    Westermark P; Natvig JB; Anders RF; Sletten K; Husby G
    Scand J Immunol; 1976; 5(1-2):31-6. PubMed ID: 57640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of renal amyloid derived from the variable region of the lambda light chain subgroup II.
    Picken MM; Gallo G; Buxbaum J; Frangione B
    Am J Pathol; 1986 Jul; 124(1):82-7. PubMed ID: 3089021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equine cutaneous amyloidosis derived from an immunoglobulin lambda-light chain. Immunohistochemical, immunochemical and chemical results.
    Linke RP; Geisel O; Mann K
    Biol Chem Hoppe Seyler; 1991 Sep; 372(9):835-43. PubMed ID: 1772596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary structure of the variable region of a human lambda VI light chain: Bence Jones protein SUT.
    Frangione B; Moloshok T; Solomon A
    J Immunol; 1983 Nov; 131(5):2490-3. PubMed ID: 6415173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid A in systemic amyloidosis associated with cancer.
    Husby G; Marhaug G; Sletten K
    Cancer Res; 1982 Apr; 42(4):1600-3. PubMed ID: 7060030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current concepts of the formation and composition of amyloid.
    Glenner GG
    Ann Clin Lab Sci; 1975; 5(4):257-63. PubMed ID: 808999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary localized amyloidosis of the eyelid: two cases of immunoglobulin light chain-derived proteins, subtype lambda V respectively lambda VI.
    Olsen KE; Sandgren O; Sletten K; Westermark P
    Clin Exp Immunol; 1996 Nov; 106(2):362-6. PubMed ID: 8918586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogold quantitation of immunoglobulin light chains in renal amyloidosis and kappa light chain nephropathy.
    Silver MM; Hearn SA; Walton JC; Lines LA; Walley VM
    Am J Pathol; 1990 May; 136(5):997-1007. PubMed ID: 1693473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical and immunochemical study of amyloid in liver affected by systemic Alambda amyloidosis with antibodies against three different regions of immunoglobulin lambda light chain.
    Kiyama M; Hoshii Y; Cui D; Kawano H; Kanda T; Ishihara T
    Pathol Int; 2007 Jun; 57(6):343-50. PubMed ID: 17539965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgD amyloid in IgD-lambda monoclonal conjunctival amyloidosis. A case report.
    Schaldenbrand JD; Keren DF
    Arch Pathol Lab Med; 1983 Dec; 107(12):626-8. PubMed ID: 6416220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organ-specific (localized) synthesis of Ig light chain amyloid.
    Hamidi Asl K; Liepnieks JJ; Nakamura M; Benson MD
    J Immunol; 1999 May; 162(9):5556-60. PubMed ID: 10228037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial amino acid sequence of an amyloid fibril protein from unusual cutaneous cystic lesions in myeloma-associated amyloidosis.
    Akiyama T; Seishima M; Nojiri M; Satoh M; Ichiki Y; Kitajima Y
    Eur J Dermatol; 1999 Dec; 9(8):624-8. PubMed ID: 10586130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial amino acid sequence of an amyloid fibril protein from nodular primary cutaneous amyloidosis showing homology to lambda immunoglobulin light chain of variable subgroup III (a lambda III).
    Kitajima Y; Hirata H; Kagawa Y; Yaoita H
    J Invest Dermatol; 1990 Sep; 95(3):301-3. PubMed ID: 2117035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AH amyloidosis associated with an immunoglobulin heavy chain variable region (VH1) fragment: a case report.
    Miyazaki D; Yazaki M; Gono T; Kametani F; Tsuchiya A; Matsuda M; Takenaka Y; Hosh Y; Ikeda S
    Amyloid; 2008 Jun; 15(2):125-8. PubMed ID: 18484339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of immunoglobulin light chain amyloid oligomers in primary cutaneous nodular amyloidosis.
    Clos AL; Lasagna-Reeves CA; Castillo-Carranza DL; Sengupta U; Jackson GR; Kelly B; Beachkofsky TM; Kayed R
    Br J Dermatol; 2011 Dec; 165(6):1349-54. PubMed ID: 21729025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodular primary cutaneous amyloidosis. Isolation and characterization of amyloid fibrils.
    Kitajima Y; Seno J; Aoki S; Tada S; Yaoita H
    Arch Dermatol; 1986 Dec; 122(12):1425-30. PubMed ID: 3789778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloidosis in rheumatoid arthritis.
    Husby G
    Ann Clin Res; 1975 Jun; 7(3):154-67. PubMed ID: 1103711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.